Skip to main content
. 2013 Aug 20;169(6):795–804. doi: 10.1530/EJE-13-0547

Table 3.

Biochemical parameters before and after parathyroid adenomectomy (PTX).

Baseline After PTX
Median IQR Median IQR P (W)
S-25-OH-D (75–250 nmol/l) 40 31–49 42 33–54 0.004
P-PTH (10–65 ng/l) 116 89–145 65 53–68 <0.001
S-Ca2+ (1.15–1.33 mmol/l) 1.43 1.39–1.43 1.25 1.22–1.27 <0.001
P-phosphate (0.75–1.4 mmol/l) 0.83 0.74–0.92 1.0 0.92–1.1 <0.001
P-creatinine (♀<90, ♂<100 μmol/l) 65 56–76 67 58–75 0.400
GFR creatinine (ml/min) 97 79–117 95 79–115 0.900
P-glucose (4.0–6.0 mmol/l)a 5.2 4.9–5.6 5.2 4.8–5.6 0.022
S-insulin (18–173 pmol/l)a 66 43–97 58 37–95 <0.001
HOMA-IRa 2.2 1.4–3.3 1.8 1.2–3.2 <0.001
S-IGF1 (110–270 μg/l) 144 117–179 138 115–172 <0.001
S-IGFBP1 30 21–49 37 21–54 0.046
S-cholesterol (3.3–7.8 mmol/l) 5.6 4.8–6.1 5.5 4.9–6.3 0.134
P-HDL (♀01.0–2.7, ♂0.8–2.1 mmol/l) 1.4 1.2–1.8 1.4 1.2–1.8 0.825
P-LDL (1.4–5.3 mmol/l) 3.5 2.8–4.1 3.5 2.8–4.1 0.161
S-triglycerides (0.45–2.6 mmol/l) 0.98 0.75–1.40 0.96 0.70–1.52 0.256

W, Wilcoxon signed-rank sum test for paired data; 25-OH-D, 25-hydroxyvitamin D; PTH, parathyroid hormone; Ca2+, ionized calcium; GFR, glomerular filtration rate; HOMA-IR, homeostatic model assessment insulin resistance; IGF1, insulin-like growth factor 1; IGFBP1, IGF-binding protein 1.

a

Patients with insulin treatment were excluded from the analysis.